Ex parte ZINKE et al. - Page 5




          Appeal No. 1997-1875                                                        
          Application No. 08/451,378                                                  


          considerations on the issue of obviousness.  In re Rinehart,                
          531 F.2d 1048, 1052, 189 USPQ 143, 147 (CCPA 1976).                         
               As rebuttal evidence, the appellants have submitted under              
          37 CFR § 1.132 a declaration executed by Dr. Horst Zinke in                 
          1994 and a declaration executed by Dr. Horst Zinke in 1995.                 
          Each of these declarations compares the same prior art                      
          compound (i.e., the compound of British reference Example 32                
          and European reference Example 1, which is said to be the                   
          closest prior art) with two compounds within the scope of                   
          independent claim 1 (i.e., the compound of specification                    
          Example 10 in the 1994 declaration and the compound of                      
          specification Example 4 in the 1995 declaration).  On page 3                
          of these respective declarations, the inventive compound is                 
          said to improve antiwear properties "significantly more" than               
          the prior art compound which is a result said to be                         
          "surprising."                                                               
               This declaration evidence is deficient in a number of                  
          respects.                                                                   
               In the first place, the rebuttal evidence is limited to                
          only two of the myriad number of compounds encompassed by                   
          appealed independent claim 1 and thus is considerably more                  
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007